Jean-Marc Maurel

A plain language summary of results from the FLAURA2 study: Effects of initial (first-line) osimertinib plus chemotherapy on the brain in patients with EGFR-mutated advanced non-small cell lung cancer

Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, Ying Cheng et autres

us, fr, jp, cn, au, pe, ru, tw, th, ca, gb (code pays fourni par la source)

A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

David Planchard, Pasi A. Jänne, Ying Cheng, James Chih‐Hsin Yang et autres

fr, us, cn, tw, jp, kr, th, ru, au, pe, gb, sk (code pays fourni par la source)

CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer

Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, Ying Cheng et autres

us, fr, jp, cn, au, pe, ru, tw, th, Afrique du Sud, cz, ca, gb (code pays fourni par la source)

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC

David Planchard, Pasi A. Jänne, Ying Cheng, James Chih‐Hsin Yang et autres

cn, fr, us (code pays fourni par la source)

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Patricio Yañez, Yuxian Bai, Fernando Rivera et autres

kr, cl, cn, es, br, gb, us, pl (code pays fourni par la source)

Practical Notes on the Current ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer in Resource-Constrained Environments of Low- to Middle-Income Countries

Jean-Marc Maurel, Maria Belen Tamayo, Rosario Pitargue, Annielyn Beryl Ong-Cornel et autres